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There is a tendency to an increase in the incidence of tumors of the central nervous system in Ukraine. 
Among the primary brain tumors in adults, glioblastomas predominate. With the growth, differentia-
tion and malignization of cells, the structure of membrane glycoproteins changes. In the oncologic 
process, there is a change in the expression of the number of glycoconjugates on the membranes of 
malignant cells. Therefore, the change in glycobiological indicators in cancers can be a priority direc-
tion of the research, namely, the development and improvement of existing methods of treatment.
The aim of the work was to establish quantitative changes in the glycosylation of leukocytes and sepa-
rately in their lymphocyte fraction upon neuro-oncological diseases.
The subject of the study were blood leukocytes of patients with brain tumors (n = 10). To isolate leu-
kocytes from human heparini zed blood, OptiLyse C lysis solution (Beckman Coulter, USA) was used. 
Separation of the lymphocytes fraction from blood was carried out in a gradient of ficoll-urografin 
density according to the modified Boyum A. The control group consisted of 10 conditionally healthy 
donors. The number of blood cells was determined by flow cytometry using mannose-specific lectin 
of the Canavalia ensiformis - Concanavalin A (ConA). The analysis was carried out using a flow cy-
tometer Соulter Epics XL. Calculation of changes in exposure density was carried out in accordance 
with the FCS Express 3 program.
The study found that the level of lymphocytes interacting with ConA was practically the same in 
normal and pathological processes, being 92.9 and 94.8%, respectively. However, the fraction of leu-
kocyte cells that contain the α-mannose residues on their surface in neuro-oncological diseases was 
90.2%, which is 1.2-folf higher than normal. This is ensured by the granulocyte and monocyte frac-
tion. 
Our results and published data allow us to confirm that the development of neuro-oncological diseases 
causes a change in the degree of glycosylation of leukocyte membranes, and can be used as an ad-
ditional diagnostic criterion.
